Rasagiline
Azilect, Rasagiline
Monoamine Oxidase Inhibitor
NADAC/unit
$1.0069
No Shortage
Tier 1: 40.1%
10 Manufacturers
20 ANDAs
indicated for the treatment of Parkinson's disease (PD).
vs. brand Azilect: Generic saves up to 90% per unit
Market Intelligence
2023-01-25 Class II Recall: Ascend Laboratories, LLC
Generic Manufacturers
ALKEM LABORATORIES LTDAUROBINDO PHARMA USA INCCARNEGIE PHARMACEUTICALS LLCCHARTWELL RX SCIENCES LLCMACLEODS PHARMACEUTICALS LTDMICRO LABS LTDORBION PHARMACEUTICALS PRIVATE LTDREGCON HOLDINGS LLCRISING PHARMA HOLDINGS INCTEVA NEUROSCIENCE INCTORRENT PHARMACEUTICALS LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.